Stockreport

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness [Read more]